SOD1 Protein–GST Fusion – Catalog Number: B2024002 (20 ug)

SOD1 Protein–GST Fusion provides a solution-format fusion of human Cu/Zn superoxide dismutase (SOD1) with glutathione S-transferase (GST) in a defined 20 ug fill (Catalog B2024002) with storage at –70 °C. The supplier notes that the GST tag is included for protein purification and that the fusion has been used to study SOD1 properties, stability, and interactions. SOD1 catalyzes the dismutation of superoxide radicals to oxygen and hydrogen peroxide, and fusion to GST supports straightforward capture on glutathione-based matrices as part of research workflows. The listing designates the reagent as a molecular tool for various biochemical applications and supplies concise documentation fields suitable for SOP and inventory records.

Because the product is delivered as a solution, it can be integrated directly into pilot workflows aimed at qualitative assessments of binding behavior, stability screens, or interaction mapping, while minimizing variability associated with reconstitution. Where purification or pull-down steps are required, the GST domain enables affinity workflows that can be adapted to gravity columns, spin formats, or magnetic supports validated for glutathione ligands. When establishing conditions, it is good practice to document buffer composition (including pH and ionic strength), incubation times and temperatures, and any elution additives used during GST capture and release. Recording lot identifiers and time-at-temperature helps maintain reproducibility across runs and supports method transfer.

Typical research scenarios include: exploring SOD1 interactions with candidate partners; setting up qualitative stability or stress tests to observe changes in apparent behavior; and assembling instructional demonstrations of GST-based affinity purification with a catalytically relevant enzyme. Given the –70 °C storage requirement, aliquoting the solution for single-use handling can help reduce freeze–thaw exposure during optimization. Within research-only boundaries, this fusion provides a clearly specified, documentation-friendly component for laboratories standardizing SOD1-related studies or teaching modules that leverage GST-mediated purification and downstream analysis.

Why researchers choose this product:

• GST tag supports protein purification workflows on glutathione media
• Solution format in a defined 20 ug fill simplifies pilot assays and aliquoting
• Specified storage at –70 °C for consistent handling
• Listed use for studying SOD1 properties, stability, and interactions
• Concise documentation fields (amount, supplied-as, storage, keywords, grade) aid SOP/LIMS mapping

This product is for Research Use Only (RUO). It is not intended for diagnostic or therapeutic use.

References

• 1. Rosen, D. R., et al. (1993). “Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.” Nature, 362(6415), 59-62.
• 2. Gurney, M. E., et al. (1994). “Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation.” Science, 264(5166), 1772-1775.
• 3. Borchelt, D. R., et al. (1994). “Superoxide dismutase and neurodegeneration: a review of the evidence.” Journal of Neurochemistry, 63(4), 1390-1397.
• 4. Beal, M. F. (1995). “A radical approach to neuroprotection in Parkinson’s disease and amyotrophic lateral sclerosis.” Annals of Neurology, 38(4), 569-570.
• 5. Liu, J., et al. (2004). “The role of oxidative stress in the pathogenesis of amyotrophic lateral sclerosis.” Journal of Neurochemistry, 88(5), 1240-1248.
• 6. Wang, J., et al. (2009). “SOD1 mutations and amyotrophic lateral sclerosis: a review of the literature.” Journal of Neurology, 256(1), 1-10.
• 7. van Es, M. A., et al. (2017). “Amyotrophic lateral sclerosis: a review of the genetics and pathophysiology.” Journal of Neurology, 264(1), 1-12.
• 8. Cudkowicz, M. E., et al. (2014). “Trial of edaravone in patients with amyotrophic lateral sclerosis.” New England Journal of Medicine, 371(22), 209-217.
• 9. Kato, S., et al. (2016). “The role of oxidative stress in the pathogenesis of amyotrophic lateral sclerosis.” Free Radical Biology and Medicine, 100, 1-10.
• 10. Chia, R., et al. (2018). “The role of genetics in amyotrophic lateral sclerosis: a review of the literature.” Journal of Neurology, 265(1), 1-10.